SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the appointment of Brandi L. Roberts as its Chief Financial Officer.

Read the rest here:
Longboard Pharmaceuticals Appoints Brandi L. Roberts as Chief Financial Officer

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *